| | |||||
| lung cancer | |||||
| 新闻 | |||||
| Deciphera Pharmaceuticals Begins ULK Kinase Inhibitor Study in RAS-, RAF-Mutated Cancers ... advanced or metastatic KRAS- or BRAF-mutated pancreatic cancer; KRAS-, NRAS-, or BRAF-mutated non-small cell lung cancer; KRAS-, NRAS-, ...
| |||||
| Chemotherapy Induced Neutropenia Market Size to Exhibit Considerable Growth at a CAGR of ... ... cancer accounting for the maximum number of Chemotherapy Induced Neutropenia prevalence out of various forms of cancers such as Lung cancer ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment